Home/Pipeline/GensuPen 2

GensuPen 2

Drug Delivery Device for Insulin

ApprovedActive

Key Facts

Indication
Drug Delivery Device for Insulin
Phase
Approved
Status
Active
Company

About Bioton

Bioton is an established, commercial-stage Polish biotech company with a strategic focus on diabetes care, primarily through its flagship biosimilar insulin product, Gensulin. The company has a fully integrated model encompassing R&D, manufacturing, and commercialization, with a significant presence in its home market and international operations. Its business is built on providing affordable, complex therapeutic solutions for diabetes, supported by patient education and digital health initiatives.

View full company profile

Therapeutic Areas